The relationship between five widely-evaluated variants in CDKN2A/B and CDKAL1 genes and the risk of type 2 diabetes: A meta-analysis

被引:26
|
作者
Peng, Feng [1 ]
Hu, Dan [2 ]
Gu, Chaohao [3 ]
Li, Xiaobo [4 ,5 ,6 ]
Li, Yuqiong [4 ,5 ,6 ]
Jia, Nan [5 ,6 ]
Chu, Shaoli [5 ,6 ]
Lin, Jinxiu [1 ]
Niu, Wenquan [4 ,6 ]
机构
[1] Fujian Med Univ, Affiliated Hosp 1, Dept Cardiol, Fuzhou, Peoples R China
[2] Fujian Med Univ, Teaching Hosp, Fujian Prov Tumor Hosp, Dept Pathol, Fuzhou, Peoples R China
[3] Sichuan Univ, Coll Comp Sci, Chengdu 610064, Peoples R China
[4] Shanghai Jiao Tong Univ, Sch Med, Ruijin Hosp, State Key Lab Med Genom, Shanghai 200030, Peoples R China
[5] Shanghai Jiao Tong Univ, Sch Med, Ruijin Hosp, Dept Hypertens, Shanghai 200030, Peoples R China
[6] Shanghai Res Inst Hypertens, Shanghai, Peoples R China
基金
中国国家自然科学基金; 上海市自然科学基金;
关键词
Type; 2; diabetes; CDKN2A/B; CDKAL1; Gene; Variant; Meta-analysis; COMMON VARIANTS; ASSOCIATION ANALYSIS; IGF2BP2; CHINESE; HHEX; POLYMORPHISMS; SLC30A8; SUSCEPTIBILITY; TCF7L2; LOCI;
D O I
10.1016/j.gene.2013.08.075
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
The genes encoding two cyclin-dependent kinases-inhibitor-2A/B (CDKN2A/B) and 5 regulatory subunit-associated protein-like 1 (CDKAL1) have been investigated extensively in associations with type 2 diabetes; the results, however, are often irreproducible. We therefore sought to evaluate these associations by performing a meta-analysis on five widely-evaluated variants from the two genes. There were 38 studies (patients/controls: 51,940/52,234) for rs10811661, 16 studies (20,029/24,419) for rs564398 in CDKN2A/B gene, and 27 studies (28,383/47,635) for rs7756992, 26 studies (28,816/31,713) for rs7754840, 21 studies (29,260/38,400) for rs10946398 in CDKAL1 gene. Overall risk estimates for type 2 diabetes conferred by rs10811661-T, rs564398-A, rs7754840-C, rs7756992-G, and rs10946398-C alleles were 1.17 (95% CI: 1.10-1.23; P < 0.0005; I-2 = 83.9%), 1.1 (95% CI: 1.0-121; P = 0.051; I-2 = 883%), 1.24 (95% CI: 1.18-1.3; P < 0.0005; I-2 = 743%), 1.2 (95% CI: 1.11-1.3; P < 0.0005; I-2 = 92.0%), and 1.19 (95% CI: 1.1-129; P < 0.0005; I-2 = 90.8%), respectively. There was evident publication bias for rs564398 and rs7754840. Subgroup analyses by ethnicity showed remarkable divergences in risk estimate for rs564398 between Asians (odds ratio [OR] = 1.01; 95% CI: 0.86-1.19; P = 0.868) and Caucasians (OR = 1.19; 95% CI: 1.03-1.35; P = 0.012) (P < 0.05). For all variants examined, the results of studies in retrospective design or with population-based controls were comparative with that of overall studies. In meta-regression analyses, age was found to exert a significant influence on the association between rs10811661 and type 2 diabetes (P = 0.003), as well as between rs7754840 and gender (P = 0.034). Taken together, our findings provide evidence for a significant contribution of CDKN2A/B gene rs10811661 and CDKAL1 gene rs7756992 and rs10946398 to type 2 diabetes. (C) 2013 Elsevier B.V. All rights reserved.
引用
收藏
页码:435 / 443
页数:9
相关论文
共 50 条
  • [21] Hematopoietically-Expressed Homeobox Gene Three Widely-Evaluated Polymorphisms and Risk for Diabetes: A Meta-Analysis
    Li, Xiaobo
    Li, Yuqiong
    Song, Bei
    Guo, Shujie
    Chu, Shaoli
    Jia, Nan
    Niu, Wenquan
    PLOS ONE, 2012, 7 (11):
  • [22] A variant in CDKAL1 influences insulin response and risk of type 2 diabetes
    Steinthorsdottir, Valgerdur
    Thorleifsson, Gudmar
    Reynisdottir, Inga
    Benediktsson, Rafn
    Jonsdottir, Thorbjorg
    Walters, G. Bragi
    Styrkarsdottir, Unnur
    Gretarsdottir, Solveig
    Emilsson, Valur
    Ghosh, Shyamali
    Baker, Adam
    Snorradottir, Steinunn
    Bjarnason, Hjordis
    Ng, Maggie C. Y.
    Hansen, Torben
    Bagger, Yu
    Wilensky, Robert L.
    Reilly, Muredach P.
    Adeyemo, Adebowale
    Chen, Yuanxiu
    Zhou, Jie
    Gudnason, Vilmundur
    Chen, Guanjie
    Huang, Hanxia
    Lashley, Kerrie
    Doumatey, Ayo
    So, Wing-Yee
    Ma, Ronald C. Y.
    Andersen, Gitte
    Borch-Johnsen, Knut
    Jorgensen, Torben
    van Vliet-Ostaptchouk, Jana V.
    Hofker, Marten H.
    Wijmenga, Cisca
    Christiansen, Claus
    Rader, Daniel J.
    Rotimi, Charles
    Gurney, Mark
    Chan, Juliana C. N.
    Pedersen, Oluf
    Sigurdsson, Gunnar
    Gulcher, Jeffrey R.
    Thorsteinsdottir, Unnur
    Kong, Augustine
    Stefansson, Kari
    NATURE GENETICS, 2007, 39 (06) : 770 - 775
  • [23] A variant in CDKAL1 influences insulin response and risk of type 2 diabetes
    Valgerdur Steinthorsdottir
    Gudmar Thorleifsson
    Inga Reynisdottir
    Rafn Benediktsson
    Thorbjorg Jonsdottir
    G Bragi Walters
    Unnur Styrkarsdottir
    Solveig Gretarsdottir
    Valur Emilsson
    Shyamali Ghosh
    Adam Baker
    Steinunn Snorradottir
    Hjordis Bjarnason
    Maggie C Y Ng
    Torben Hansen
    Yu Bagger
    Robert L Wilensky
    Muredach P Reilly
    Adebowale Adeyemo
    Yuanxiu Chen
    Jie Zhou
    Vilmundur Gudnason
    Guanjie Chen
    Hanxia Huang
    Kerrie Lashley
    Ayo Doumatey
    Wing-Yee So
    Ronald C Y Ma
    Gitte Andersen
    Knut Borch-Johnsen
    Torben Jorgensen
    Jana V van Vliet-Ostaptchouk
    Marten H Hofker
    Cisca Wijmenga
    Claus Christiansen
    Daniel J Rader
    Charles Rotimi
    Mark Gurney
    Juliana C N Chan
    Oluf Pedersen
    Gunnar Sigurdsson
    Jeffrey R Gulcher
    Unnur Thorsteinsdottir
    Augustine Kong
    Kari Stefansson
    Nature Genetics, 2007, 39 : 770 - 775
  • [24] Variants in the FTO and CDKAL1 loci have recessive effects on risk of obesity and type 2 diabetes, respectively
    Wood, Andrew R.
    Tyrrell, Jessica
    Beaumont, Robin
    Jones, Samuel E.
    Tuke, Marcus A.
    Ruth, Katherine S.
    Yaghootkar, Hanieh
    Freathy, Rachel M.
    Murray, Anna
    Frayling, Timothy M.
    Weedon, Michael N.
    DIABETOLOGIA, 2016, 59 (06) : 1214 - 1221
  • [25] Association of CDKAL1 RS10946398 Gene Polymorphism with Susceptibility to Diabetes Mellitus Type 2: A Meta-Analysis
    Xu, Ning
    Zhang, Ting-Ting
    Han, Wen-Jia
    Yin, Li-Ping
    Ma, Nan-Zheng
    Shi, Xiu-Yan
    Sun, Jiang-Jie
    JOURNAL OF DIABETES RESEARCH, 2021, 2021
  • [26] CDKN2A/B rs4977756 and glioma risk: a meta-analysis
    Wang, Dongsheng
    Zhang, Hongqiang
    Yuan, Zhongbo
    Yu, Zhikuan
    Yang, Ting
    Zhang, Bo
    Liu, Yang
    Jia, Xiaoxue
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2016, 9 (02): : 2590 - 2594
  • [27] Variants in the FTO and CDKAL1 loci have recessive effects on risk of obesity and type 2 diabetes, respectively
    Andrew R. Wood
    Jessica Tyrrell
    Robin Beaumont
    Samuel E. Jones
    Marcus A. Tuke
    Katherine S. Ruth
    Hanieh Yaghootkar
    Rachel M. Freathy
    Anna Murray
    Timothy M. Frayling
    Michael N. Weedon
    Diabetologia, 2016, 59 : 1214 - 1221
  • [28] Islet biology, the CDKN2A/B locus and type 2 diabetes risk
    Yahui Kong
    Rohit B. Sharma
    Benjamin U. Nwosu
    Laura C. Alonso
    Diabetologia, 2016, 59 : 1579 - 1593
  • [29] Islet biology, the CDKN2A/B locus and type 2 diabetes risk
    Kong, Yahui
    Sharma, Rohit B.
    Nwosu, Benjamin U.
    Alonso, Laura C.
    DIABETOLOGIA, 2016, 59 (08) : 1579 - 1593
  • [30] Association of CDKAL1, IGF2BP2, CDKN2A/B, HHEX, SLC30A8, and KCNJ11 with susceptibility to type 2 diabetes in a Japanese population
    Mori, Shintaro
    Tanaka, Yasushi
    Takahashi, Atsushi
    Hirose, Hiroshi
    Kashiwagi, Atsunori
    Kaku, Kohei
    Kawamori, Ryuzo
    Nakamura, Yusuke
    Maeda, Shiro
    DIABETES, 2008, 57 (03) : 791 - 795